Skip to main content
OpenTrials

Clinical trial condition

Fibrolamellar hepatocellular carcinoma

Explore clinical trials studying Fibrolamellar hepatocellular carcinoma. Study availability and eligibility vary by location and protocol.

16 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Fibrolamellar hepatocellular carcinoma trial results

Recruiting

Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma

NCT06620302

Conditions
Childhood Fibrolamellar Carcinoma, Fibrolamellar hepatocellular carcinoma, Recurrent Childhood Fibrolamellar Carcinoma, +7 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 21 locations
View Trial Details
Recruiting

Agnostic Therapy in Rare Solid Tumors

NCT06638931

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
Locations
  • Hospital São Carlos Fortaleza, Ceará, Brazil
  • Hospital São Rafael Salvador, Estado de Bahia, Brazil
  • Hospital Santa Cruz Curitiba, Paraná, Brazil
  • IDOR Recife Recife, Pernambuco, Brazil
View Trial Details
Recruiting

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

NCT04134559

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Cincinnati Children's Medical Center Cincinnati, Ohio, United States
View Trial Details

Related conditions